OTCQB Approval

Summary by AI BETAClose X

Valereum Plc has announced its ordinary shares have been approved for cross-trading on the OTCQB Venture Market in the United States, commencing on March 4, 2026, under the ticker symbol VLRMF. This approval signifies Valereum's adherence to financial reporting and governance standards, expanding its investor base to the US capital markets, potentially enhancing liquidity and visibility. The company views this as a strategic step towards its long-term goal of a major US exchange listing, leveraging its presence in the US trading infrastructure to engage with American investors as it develops its tokenised digital markets.

Disclaimer*

Valereum PLC
04 March 2026
 

horizontal line

Date: 4 March 2026

FOR IMMEDIATE RELEASE (Aquis Stock Exchange: VLRM)

Valereum Plc

("Valereum", "VLRM" or the "Company")

OTCQB Approval - Access to US Capital Markets

Valereum Plc (AQSE: VLRM), a company aiming to become the global market leader in the rapidly developing tokenised digital markets sector, is pleased to announce that its ordinary shares have been approved for cross-trading on the OTCQB Venture Market in the United States and will commence trading under the ticker symbol VLRMF with effect from 4 March 2026.

The OTCQB Market, operated by OTC Markets Group Inc., is recognised as an established marketplace for entrepreneurial and growth-stage companies that meet defined standards of financial reporting, governance and compliance. Approval to trade on the OTCQB reflects Valereum's commitment to transparency and regulatory standards and enables broader accessibility for US-based institutional and retail investors. Admission to the OTCQB materially expands the Company's potential investor audience by providing access to the world's largest capital market. It is expected to enhance liquidity, improve price discovery and increase our visibility across North America.

The Board views OTCQB trading as a significant step within Valereum's long-term strategy. Establishing a presence within US trading infrastructure enables engagement with American investors and leads towards a potential major US exchange listing, subject to satisfying applicable requirements.

As Valereum continues to develop its regulated real-world asset and digital markets infrastructure, it now has a firm footing in the US, via a direct and decentralised market.

James Bannon, Executive Chair of Valereum Plc, commented:

"OTCQB approval is a great development for Valereum. It gives us access to US capital markets, significantly widens our potential investor base, and supports our longer-term ambition of establishing a deeper presence in the States. Another ticked box in our plan for global growth."

For further information, please contact:

Valereum Plc

Karl Moss

 Tel: +44 7938 767319 

Investor Hub

Fortified Securities

Guy Wheatley                        

 

Tel: +44 203 4117773                 

Aquis Corporate Adviser   

Guild Financial Advisory Limited

Ross Andrews

 

 

E: ross.andrews@guildfin.co.uk

The Directors of the Company accept responsibility for the contents of this announcement.

Please visit the Company's website at www.vlrm.com

For more information, and the chance to have your questions directly answered by the management team, please head to our interactive investor hub via: Investor Hub.

IMPORTANT NOTICES

The Company holds cryptocurrencies or crypto assets in its treasury. Whilst the Board of Directors of the Company considers holding cryptocurrencies to be in the best interests of the Company, the Board remains aware that the financial regulator in the UK (the Financial Conduct Authority or FCA) considers investment in cryptocurrencies to be high risk. At the outset, it is important to note that an investment in the Company is not an investment in cryptocurrencies, either directly or by proxy and shareholders will have no direct access to the Company's holdings. However, the Board of Directors consider cryptocurrencies to be an appropriate store of value and potential growth and therefore appropriate for the Company. Accordingly, the Company is and intends to continue to be materially exposed to cryptocurrencies.

 The Company is neither authorised nor regulated by the FCA, and the purchase of certain cryptocurrencies are generally unregulated in the UK. As with most other investments, the value of cryptocurrencies can go down as well as up, and therefore the value of the Company's cryptocurrencies holdings can fluctuate. The Company may not be able to realise its cryptocurrencies holdings for the same as it paid to acquire them or even for the value the Company currently ascribes to its cryptocurrencies positions due to market movements. Neither the Company nor investors in the Company's shares are protected by the UK's Financial Ombudsman Service or the Financial Services Compensation Scheme.

 Cryptocurrencies may present special risks to the Company's financial position. These risks include (but are not limited to): (i) the value of cryptocurrencies can be highly volatile, with value dropping as quickly as it can rise. Investors in cryptocurrencies must be prepared to lose all money invested in cryptocurrencies; (ii) the cryptocurrencies market is largely unregulated. There is a risk of losing money due to risks such as cyber-attacks, financial crime and counterparty failure; (iii) the Company may not be able to sell its cryptocurrencies at will. The ability to sell cryptocurrencies depends on various factors, including the supply and demand in the market at the relevant time. Operational failings such as technology outages, cyber-attacks and commingling of funds could cause unwanted delay; and (iv) crypto assets are characterised in some quarters by high degrees of fraud, money laundering and financial crime. Prospective investors in the Company are encouraged to do their own research before investing.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings